Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Clinical trial NCT04158635 · SUSPENDED

Trial details

NCT number: NCT04158635
Sponsor: City of Hope Medical Center
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 Unresectable Pancreatic Carcinoma

Start date: 2021-09-01
Primary completion: 2027-03-09
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.